These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32304958)

  • 1. Incidence of residual neuromuscular blockade and use of neuromuscular blocking agents with or without antagonists: A systematic review and meta-analysis of randomized controlled trials.
    Raval AD; Uyei J; Karabis A; Bash LD; Brull SJ
    J Clin Anesth; 2020 Apr; 64():109818. PubMed ID: 32304958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and outcomes of residual neuromuscular blockade: A systematic review of observational studies.
    Raval AD; Anupindi VR; Ferrufino CP; Arper DL; Bash LD; Brull SJ
    J Clin Anesth; 2020 Nov; 66():109962. PubMed ID: 32585565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007362. PubMed ID: 19821409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada.
    Insinga RP; Joyal C; Goyette A; Galarneau A
    BMC Anesthesiol; 2016 Nov; 16(1):114. PubMed ID: 27852231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
    Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
    J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study.
    Domenech G; Kampel MA; García Guzzo ME; Novas DS; Terrasa SA; Fornari GG
    BMC Anesthesiol; 2019 Aug; 19(1):143. PubMed ID: 31390986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual neuromuscular blockade in a real life clinical setting: correlation with sugammadex or neostigmine administration.
    Batistaki C; Tentes P; Deligiannidi P; Karakosta A; Florou P; Kostopanagiotou G
    Minerva Anestesiol; 2016 May; 82(5):550-8. PubMed ID: 26394365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual neuromuscular block in the postanesthesia care unit: incidence, risk factors, and effect of neuromuscular monitoring and reversal agents.
    Özbey NB; Abdullah T; Deligöz Ö
    Turk J Med Sci; 2022 Oct; 52(5):1656-1664. PubMed ID: 36422506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
    Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
    Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual neuromuscular blockade and late neuromuscular blockade at the post-anesthetic recovery unit: prospective cohort study.
    Gonçalves PMSE; Vieira AV; Silva CHRD; Gomez RS
    Braz J Anesthesiol; 2021; 71(1):38-43. PubMed ID: 33712250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
    Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N
    Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
    Carron M; Zarantonello F; Tellaroli P; Ori C
    J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of postoperative residual neuromuscular blockade - A multicenter, observational study in Portugal (INSPIRE 2).
    Esteves S; Correia de Barros F; Nunes CS; Puga A; Gomes B; Abelha F; Machado H; Ferreira M; Fernandes N; Vítor P; Pereira S; Lapa TA; Pinho-Oliveira V
    Porto Biomed J; 2023; 8(4):e225. PubMed ID: 37547706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Half-Dose Sugammadex After Neostigmine Versus Neostigmine as a Routine Reversal Agent: A Pilot Randomized Trial.
    Baysal A; Sagıroglu G; Dogukan M; Ozkaynak I
    J Perianesth Nurs; 2022 Jun; 37(3):326-332. PubMed ID: 35153119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between first-twitch depression and train-of-four ratio during sugammadex reversal of rocuronium-induced neuromuscular blockade.
    Kim KS; Oh YN; Kim TY; Oh SY; Sin YH
    Korean J Anesthesiol; 2016 Jun; 69(3):239-43. PubMed ID: 27274368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of early postoperative muscle strength after deep neuromuscular block by means of ultrasonography with comparison of neostigmine versus sugammadex as reversal drugs: study protocol for a randomised controlled trial.
    Wang X; Li Y; Huang C; Xiong W; Zhou Q; Niu L; Xiao Y
    BMJ Open; 2021 Feb; 11(2):e043935. PubMed ID: 33637547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study.
    Saager L; Maiese EM; Bash LD; Meyer TA; Minkowitz H; Groudine S; Philip BK; Tanaka P; Gan TJ; Rodriguez-Blanco Y; Soto R; Heisel O
    J Clin Anesth; 2019 Aug; 55():33-41. PubMed ID: 30594097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study.
    Voss T; Wang A; DeAngelis M; Speek M; Saldien V; Hammer GB; Wrishko R; Herring WJ
    Paediatr Anaesth; 2022 Mar; 32(3):436-445. PubMed ID: 34878707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.